MRK · ISSUER CIK 310158
Merck & Co., Inc.
Between Aug 1, 2026 and Oct 29, 2026, 5 Merck & Co., Inc. insiders reported $0.00 of open-market purchases and $30.0M of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 7 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$30.0MInsider selling
−$30.0MNet open-market
Aug 13, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 202617:02 | Aug 13, 2026 | MRK | EVP, Access, Policy & Comms | S · Sell | $135.00 | −10,000 | 36,613 | -21% | −$1.4M | ||
| Aug 13, 202616:11 | Aug 12, 2026 | MRK | EVP, General Counsel | S · Sell | $133.46 | −80,315 | 45,509 | -64% | −$10.7M | ||
| Aug 13, 202616:11 | Aug 12, 2026 | MRK | EVP, General Counsel | M · Exercise | $109.78 | +54,927 | 125,824 | +77% | $6.0M | ||
| Aug 12, 202616:10 | Aug 12, 2026from Aug 10, 2026 | MRK | EVP&Pres, Merck Animal Heallth | S · Sell | $131.12 | −45,320 | 110,167 | -29% | −$5.9M | ||
| Aug 10, 202616:28 | Aug 6, 2026 | MRK | EVP&Pres, Merck Animal Heallth | S · Sell | $130.38 | −6,050 | 155,487 | -4% | −$789K | ||
| Aug 7, 202616:21 | Aug 5, 2026 | MRK | EVP & Pres. MMD | S · Sell | $128.72 | −18,706 | 18,212 | -51% | −$2.4M | ||
| Aug 7, 202616:21 | Aug 5, 2026 | MRK | EVP & Pres. MMD | M · Exercise | $82.25 | +18,706 | 20,898 | +853% | $1.5M | ||
| Aug 7, 202616:19 | Aug 5, 2026 | MRK | EVP,Chief Info&Digital Officer | S · Sell | $128.77 | −52,847 | 31,716 | -62% | −$6.8M | ||
| Aug 7, 202616:19 | Aug 5, 2026 | MRK | EVP,Chief Info&Digital Officer | M · Exercise | $74.49 | +52,847 | 66,421 | +389% | $3.9M | ||
| Aug 7, 202616:17 | Aug 6, 2026 | MRK | EVP, Access, Policy & Comms | S · Sell | $131.00 | −15,000 | 46,613 | -24% | −$2.0M |